Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Sander, B."" wg kryterium: Wszystkie pola


Tytuł:
SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer
Autorzy:
Sheng-You Liao
Dmytro Rudoy
Sander B. Frank
Luan T. Phan
Olga Klezovitch
Julian Kwan
Ilsa Coleman
Michael C. Haffner
Dapei Li
Peter S. Nelson
Andrew Emili
Valeri Vasioukhin
Pokaż więcej
Temat:
Science
Źródło:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2041-1723
Dostęp URL:
https://doaj.org/article/4403e3302e9b4f26a416658e94332b3c  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
LAPped in Proof: LC3‐Associated Phagocytosis and the Arms Race Against Bacterial Pathogens
Autorzy:
Bart J. M. Grijmans
Sander B. van der Kooij
Monica Varela
Annemarie H. Meijer
Pokaż więcej
Temat:
LC3-associated phagocytosis
macrophages
neutrophils
autophagy
innate immunity
intracellular pathogens
Microbiology
QR1-502
Źródło:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.frontiersin.org/articles/10.3389/fcimb.2021.809121/full; https://doaj.org/toc/2235-2988
Dostęp URL:
https://doaj.org/article/edded5404bf34dcf9a093f15c094990b  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Autorzy:
Passos-Castilho AM; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Murphy DG; Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.
Blouin K; Unité sur les Infections Transmissibles Sexuellement et par le Sang, Institut National de Santé Publique du Québec, Québec, QC H9X 3R5, Canada.
Benedetti A; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Panagiotoglou D; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Bruneau J; CHUM Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Klein MB; Research Institute of the McGill University Health Centre, Montreal, QC H3H 2R9, Canada.
Kwong JC; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.
Sander B; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.; Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, Toronto, ON M5T 3M6, Canada.
Janjua NZ; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Greenaway C; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.; Division of Infectious Diseases, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Pokaż więcej
Źródło:
Viruses [Viruses] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Retrospective Studies ; Cohort Studies ; Canada/epidemiology ; RNA
Czasopismo naukowe
Tytuł:
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study
Autorzy:
Snoeren, Nikol
Pokaż więcej
Źródło:
In Neoplasia February 2017 19(2):93-99
Czasopismo naukowe
Tytuł:
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis.
Autorzy:
Zeitouny S; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, British Columbia, Canada.; Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Cheung DC; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.; Divisions of Urology and Surgical Oncology, Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Bremner KE; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.
Pataky RE; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Pequeno P; ICES, Toronto, Ontario, Canada.
Matelski J; Biostatistics Research Unit, University Health Network, Toronto, Ontario, Canada.
Peacock S; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, British Columbia, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
Del Giudice ME; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Lapointe-Shaw L; ICES, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.; Department of General Internal Medicine, Toronto General Hospital, Toronto, Ontario, Canada.
Tomlinson G; Biostatistics Research Unit, University Health Network, Toronto, Ontario, Canada.
Mendlowitz AB; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.; Toronto Centre for Liver Disease/Viral Hepatitis Care Network (VIRCAN), University Health Network, Toronto, Ontario, Canada.; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Mulder C; Chiefs of Ontario, Toronto, Ontario, Canada.; Queen's University, Kingston, Ontario, Canada.
Tsui TCO; ICES, Toronto, Ontario, Canada.; Child Health and Evaluative Sciences, Hospital for Sick Children, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Toronto, Ontario, Canada.; Canadian Centre for Applied Research in Cancer Control, Ontario Health-Cancer Care Ontario, Toronto, Ontario, Canada.
Perlis N; Divisions of Urology and Surgical Oncology, Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Urology, Sprott Department of Surgery, University Health Network, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Walker JD; ICES, Toronto, Ontario, Canada.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Sander B; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Wong WWL; ICES, Toronto, Ontario, Canada.; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.
Krahn MD; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Kulkarni GS; Divisions of Urology and Surgical Oncology, Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; ICES, Toronto, Ontario, Canada.; Division of Urology, Sprott Department of Surgery, University Health Network, Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 08; Vol. 18 (9), pp. e0290646. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pandemics*
COVID-19*/epidemiology
Humans ; Interrupted Time Series Analysis ; Cross-Sectional Studies ; Retrospective Studies ; SARS-CoV-2 ; Renal Dialysis ; British Columbia ; Health Care Costs
Czasopismo naukowe
Tytuł:
Inclusion of non-medical interventions in model-based economic evaluations for tuberculosis: A scoping review.
Autorzy:
Ramsay LC; University of Toronto, Toronto, ON, Canada.; University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada.
Marina Richardson; University of Toronto, Toronto, ON, Canada.; University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada.
Miranda RN; University of Toronto, Toronto, ON, Canada.; University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada.
Hassan M; University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada.
Brode SK; University of Toronto, Toronto, ON, Canada.; West Park Healthcare Centre, Toronto, ON, Canada.; Department of Medicine, University Health Network, Toronto, ON, Canada.
Rea E; University of Toronto, Toronto, ON, Canada.; Toronto Public Health, Toronto, ON, Canada.
Sander B; University of Toronto, Toronto, ON, Canada.; University Health Network, Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada.; Public Health Ontario, Toronto, ON, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 25; Vol. 18 (8), pp. e0290710. Date of Electronic Publication: 2023 Aug 25 (Print Publication: 2023).
Typ publikacji:
Review; Journal Article
MeSH Terms:
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Emigrants and Immigrants*
Humans ; Cost-Benefit Analysis ; Databases, Factual ; Food
Czasopismo naukowe
Tytuł:
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study
Autorzy:
Nikol Snoeren
Richard van Hillegersberg
Sander B. Schouten
Andre M. Bergman
Erikv van Werkhoven
Otilia Dalesio
Rob A.E.M. Tollenaar
Henk M. Verheul
Joost van der Sijp
Inne H.M. Borel Rinkes
E.E. Voest
Pokaż więcej
Temat:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 2, Pp 93-99 (2017)
Opis pliku:
electronic resource
Relacje:
http://www.sciencedirect.com/science/article/pii/S1476558616301701; https://doaj.org/toc/1476-5586; https://doaj.org/toc/1522-8002
Dostęp URL:
https://doaj.org/article/8540aee29ed24edfb5097530285c804e  Link otwiera się w nowym oknie
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies